Tongyi Zhang Hongwei Wang Zhiwei Cai Siqi Zhang Chongyi Jiang
10.3389/fonc.2023.1078076
Front Oncol
2023 Apr 17;13:1078076.
ret fusion ret inhibitors pancreatic cancer pralsetinib target therapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/37139148/
Case Reports
PMC10149926
37139148
RET rearrangement-positive pancreatic cancer has remarkable response to pralsetinib: a case report
2023